$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
奥希替尼一线治疗中耐药数据亮相2018ESMO大会
2025-10-19 11:44:20
Check Details
奥希替尼如何贮藏?
2025-10-19 11:44:20
Check Details
奥希替尼纳入医保后价格降幅71%
2025-10-19 11:44:20
Check Details
克唑替尼与哪些药物会产生相互作用
2025-10-19 11:44:20
Check Details
奥希替尼获批治疗T790M突变阳性NSCLC
2025-10-19 11:44:20
Check Details
克唑替尼治疗ALK+NSCLC患者生存期延长
2025-10-19 11:44:20
Check Details
奥希替尼在治疗晚期NCLC的治疗效果怎么样?
2025-10-19 11:44:20
Check Details
克唑替尼的多点位适应症
2025-10-19 11:44:20
Check Details
奥希替尼可用于一代靶向耐药的肺癌患者
2025-10-19 11:44:20
Check Details
奥希替尼有针对性治疗EGFR一代耐药的患者
2025-10-19 11:44:20
Check Details
儿童和心脏疾病患者不推荐服用奥希替尼
2025-10-19 11:44:20
Check Details
艾乐替尼vs克唑替尼治疗ALK阳性非小细胞肺癌
2025-10-19 11:44:20
Check Details
1
2
...
9023
9024
9025
9026
9027
9028
9029
...
10207
10208
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
IRX4 Transcription Factor: New Research Insights on Colorectal Cancer Treatment Targets
2
Ponesimod PONVORY: Novel Oral Treatment Option for Multiple Sclerosis
3
Lemborexant Side Effects and Medication Safety Complete Guide
4
Pegcetacoplan Side Effects and Medication Safety Complete Guide
5
Cabotegravir Sodium Side Effects and Medication Safety Complete Guide
6
Vericiguat Side Effects and Medication Safety Complete Guide
7
New Research Progress on Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Tumor Relationship
8
Pegcetacoplan (Empaveli): Complete Guide to PNH Complement Inhibitor Treatment
9
Cabotegravir Sodium (Vocabria): Complete Guide to HIV Long-Acting Treatment and Prevention
10
Eltrombopag: Innovative TPO Receptor Agonist for Treating Thrombocytopenia - Comprehensive Drug Analysis
11
Tyrosine Kinase and JAK Inhibitors May Increase Keratinocyte Carcinoma Risk: New Research Reveals Drug Safety Findings
12
CLISGen Database: A New Tool for Cell Line Selection in Cancer Genetic Variation Research